Who We Are
A Medebound HEALTH Company
ChinaCureLink is the dedicated China-access arm of Medebound HEALTH, an international healthcare company that is incorporated and headquartered in New York, and has its operations in North America, and Asia Pacific. It is dedicated to assisting patients across the globe to gain easy access to top medical experts and advanced treatment methods when they encounter frustrating and devastating conditions. Medebound HEALTH has contracted with the world’s largest insurance firms (global Fortune 500 companies) and has successfully acquired worldwide members touching over two million lives, bringing new hope to patients who would otherwise have to travel abroad for care.
While Medebound HEALTH connects patients worldwide with top U.S. medical experts for second opinions and advanced treatment guidance, ChinaCureLink was built to solve a more specific problem: getting international patients fast, informed access to cutting-edge cell and gene therapies — CAR-T therapy, stem cell treatment, and other advanced oncology and hematology care — available in China's leading hospitals.
Founders and Heritage
ChinaCureLink was built on the same foundation as Medebound HEALTH. Since 1991, our co-founders' work in identifying America's top physicians — through Castle Connolly Medical Ltd., the nation's leading physician-recommendation company — laid the groundwork for a simple belief: patients deserve a trusted, expert-vetted path to the right care, wherever in the world that care exists.
That belief is what led Dr. Sheena Liu, co-founder of Medebound HEALTH, to extend the company's mission into China — building direct relationships with the country's top hematology and oncology hospitals so that international patients could access CAR-T and cell therapy breakthroughs without navigating an unfamiliar system alone.
Present and Future
Through a fruitful collaboration with Castle and Connolly, Dr. Sheena Liu, who co-founded Medebound HEALTH, has embarked on the business with a focus on second opinion services, and global access to innovative treatment with the mission of saving lives. To date, we have hand-picked and signed up the nation’s top 1% of doctors totaling 1000+ Top US physicians in every medical discipline who are readily available to provide their expertise in assisting patients globally.
Today, ChinaCureLink works hand-in-hand with top China's leading treatment centers to give patients a full picture of their options and direct, coordinated access to advanced China-based therapies when that's the best path forward. Our focus is singular: help patients reach the treatment that can actually change their outcome, as quickly and safely as possible.
Our Vision and Mission
Empowering Patients Worldwide to Access the Best Possible Care, No Matter Where They Are!
Accessing to the Life-Changing Treatment Options.
Meet The Leadership
Sheena Liu
Co-founder and CEO
Physician from the 2nd best (American founded)hospital in China; PhD in Biomedical Informatics from Columbia; Team lead at Royal Philips (Global 500) and senior scientist with15+ patents; Director of Informatics at a large pharma Boehringer Ingelheim (Global 500): managed and executed a high-profile informatics program with collaboration with 100+ US Top hospitals; Former Editorial board member of IEEE EMBS
John Connolly
Co-founder, Director of Medical Liason
The nation's foremost expert on identifying top physicians. Former president of New York Medical College for 10+ years. Serial entrepreneur with successful exit. Co-Founder of Castle Connolly Medical Ltd, Chairman of Castle Connolly Private Health Partners, among others. Dr. Connolly has been a leader in healthcare for over 30 years. He is a graduate of Columbia University (Ed.D) and has been awarded three honorary doctorates
John Castle
Co-founder and Director
A prominent investor and a member of The New York Presbyterian Hospital Board of Trustees. Has served on various committees at Harvard, including the Harvard Business School. He has been a member of the board of the MIT/Harvard Whitehead Institute. Former Chairman of the Board of New York Medical College for 22 years. Founder and President of Castle Harlan, a private equity firm which has completed over 50 acquisitions with a total value of approximately $10 billion.
Dexter Sun
Director, Asia
Dr. Sun is a board-certified physician, a tenured full professor, and serves as the trustee board member at Weill Cornell Medical College with affiliations at both the New York-Presbyterian Hospital and the Hospital For Special Surgery. Fluent in English, Chinese, and conversational Arabic, Dr. Sun is also a successful serial entrepreneur with a global vision.
David White
Medical Director and Professor at Harvard Medical School. Dr. White served as Chief Medical Officer (CMO) Emeritus of Philips Home Healthcare (a $6 billion business unit). He was also previously Chief Medical Officer of Respironics (acquired for $5 billion). Dr. White graduated from Emory University School of Medicine and completed his residency in internal medicine and pulmonary medicine at the University of Colorado Health Sciences Center.
Dr. Flores, Chair of Thoracic Surgery at Mount Sinai Hospital, Speaking of Medebound HEALTH Telehealth Services
MEDEBOUND HEALTH HAS AN EXTRAORDINARILY IMPORTANT CONTRIBUTION TO BE MADE...
THE TELEMEDICINE OF MEDEBOUND HEALTH
IS A GREAT SERVICE...
Mr. Castle, President of Castle Harlan, Trustee Board member of New York-Presbyterian Hospital, Speaking of Medebound HEALTH Telehealth Services
Our Select Global Clients
